Illness	Number of cases
Malignant neoplasm of breast (C50.4)	702
Benign neoplasm of breast (D24)	232
Carcinoma in situ of breast (D05.1)	222
Malignant neoplasm of breast (C50.2)	156
Malignant neoplasm of breast (C50.5)	125
Complications of other internal prosthetic devices implants and grafts (T85.82)	98
Malignant neoplasm of breast (C50.1)	82
Malignant neoplasm of breast (C50.3)	63
Complications of other internal prosthetic devices implants and grafts (T85.4)	44
Prophylactic surgery - Encounter for prophylactic removal of unspecified organ (Z40.00)	43

Top 10 treatments

Treatment	Number
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a2)	1.115
Gamma probe measurement when removing a particular lymph node in cancerous diseases, e.g. with breast cancer (3-760)	781
Surgical removal of individual lymph nodes or lymphatic vessels (5-401.11)	775
Revision operations (5-983)	549
Other reconstructive operations on the breast (5-886.30)	190
Breast-conserving surgical removal of breast tissue, without taking the axillary lymph nodes (5-870.a1)	152
Surgical removal of the breast (mastectomy), without taking the axillary lymph nodes (5-872.1)	141
(5-877.20)	122
Operation to divide adhesions around a nerve or to relieve pressure on the nerve or to abolish the nerve function (5-056.x)	112
Gamma probe measurement to localise a tumour (3-762)	82

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2400

Type of specialist department

Inpatient department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Das Krankenhaus Jerusalem ist durch die Behandlung von Brustkrebspatientinnen des Mamma-Zentrum Hamburg am Disease-Management-Programm Brustkrebs beteiligt, ein eigener Vertrag besteht nicht.

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
0	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies	Die Clinical Trials Hamburg Studiengesellschaft nimmt zzt. an > 20 klinischen Studien d. Phasen II - IV, nicht-interventionellen Beobachtungen u. weiteren Forschungsprojekten zur Diagnostik u. Behandlung von soliden Tumoren u. supportiven Therapiezielen teil.
Student training (clinical traineeship / internship year)	Betreuung von Dissertationen
Participation in multi-centre phase III/IV studies	s. FL05
Lectureships / teaching posts at colleges and universities